BrainChild Bio is a kids-first, clinical-stage biotechnology company specializing in CAR-T cell technology for central nervous system tumors. Focused on treating diffuse intrinsic pontine glioma (DIPG) in pediatrics and expanding to other brain tumors and metastases, the company aims to optimize CAR-T applications and advance therapies for both pediatric and adult patients.
BrainChild Bio is seeking a Director, Regulatory Affairs, to lead and execute the regulatory strategy for our CAR T programs.
BrainChild Bio is a kids-first, clinical-stage biotechnology company specializing in CAR-T cell technology for central nervous system tumors. Focused on treating diffuse intrinsic pontine glioma (DIPG) in pediatrics and expanding to other brain tumors and metastases, the company aims to optimize CAR-T applications and advance therapies for both pediatric and adult patients.